Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weizhou Hou

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2016
Noninvasive Imaging of Fluorescent Reporters in Small Rodent Models Using Fluorescence Molecular TomographyWeizhou Hou, Steve H Thorne
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2013
Regulating cytokine function enhances safety and activity of genetic cancer therapiesHannah Chen, Padma Sampath, Weizhou Hou, et al.
Cancer Cell|July 5, 2016
Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to ImmunotherapyWeizhou Hou, Padma Sampath, Juan J Rojas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2015
Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic VirotherapyJuan J Rojas, Padma Sampath, Weizhou Hou, et al.
International Journal of Cancer|January 30, 2014
Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGFWeizhou Hou, Hannah Chen, Juan Rojas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effectsPadma Sampath, Jun Li, Weizhou Hou, et al.
Journal for Immunotherapy of Cancer|February 27, 2020
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiencyFeng Li, Yuqiao Sheng, Weizhou Hou, et al.
Cell Reports|April 7, 2016
Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer TherapiesJuan J Rojas, Padma Sampath, Braulio Bonilla, et al.
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeShaojuan Zhang, Pin Shao, Xiaoxi Ling, et al.
Plos One|August 16, 2014
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regionsErica C Nakajima, Charles Laymon, Matthew Oborski, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2016
Noninvasive Imaging of Fluorescent Reporters in Small Rodent Models Using Fluorescence Molecular TomographyWeizhou Hou, Steve H Thorne
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2013
Regulating cytokine function enhances safety and activity of genetic cancer therapiesHannah Chen, Padma Sampath, Weizhou Hou, et al.
Cancer Cell|July 5, 2016
Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to ImmunotherapyWeizhou Hou, Padma Sampath, Juan J Rojas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2015
Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic VirotherapyJuan J Rojas, Padma Sampath, Weizhou Hou, et al.
International Journal of Cancer|January 30, 2014
Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGFWeizhou Hou, Hannah Chen, Juan Rojas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effectsPadma Sampath, Jun Li, Weizhou Hou, et al.
Journal for Immunotherapy of Cancer|February 27, 2020
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiencyFeng Li, Yuqiao Sheng, Weizhou Hou, et al.
Cell Reports|April 7, 2016
Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer TherapiesJuan J Rojas, Padma Sampath, Braulio Bonilla, et al.
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeShaojuan Zhang, Pin Shao, Xiaoxi Ling, et al.
Plos One|August 16, 2014
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regionsErica C Nakajima, Charles Laymon, Matthew Oborski, et al.
Pageof 2